top of page
Writer's pictureYoona

The Global Rise of Gut Health Issues and the Power of ILDONG Bioscience’s JPL934® Probiotics Blend

Updated: Oct 21

In recent years, gastrointestinal disorders have become an increasingly prevalent global health issue. According to the World Health Organization (WHO), over 600 million people worldwide suffer from various digestive problems, including irritable bowel syndrome (IBS), chronic constipation, and bloating. This number continues to rise, and the demand for solutions to improve gut health is growing alongside it.

In the United States alone, it is estimated that 10-15% of the population experiences gastrointestinal issues, making gut health a major concern. The U.S. market for gut health-related products reached a staggering $20 billion in 2022. Europe’s market is close behind, valued at $15 billion, with countries like Germany and the UK seeing rapid growth. In the Asia-Pacific region, the market for probiotics and gut health supplements is expanding quickly, particularly in South Korea and Japan, where health supplement markets are growing at over 6% annually.


Why Gut Health Matters

The increasing awareness of gut health's importance is driving the global probiotics market. Maintaining a healthy gut microbiome is not just essential for digestion but also for overall well-being, as gut health has been linked to immune function, mental health, and even skin health. Probiotics are becoming a popular choice for those looking to support and maintain a healthy gut, as they help balance the beneficial bacteria in the intestines.


The Solution: ILDONG Bioscience’s JPL934® Probiotic

ILDONG Bioscience has been at the forefront of developing innovative probiotic solutions, and one of its standout products is JPL934®. This premium probiotic ingredient is a blend of three clinically studied strains: Lactobacillus johnsonii, Lactobacillus plantarum, and Bifidobacterium lactis. These strains have been proven to be effective in promoting digestive health and alleviating common gastrointestinal symptoms.

A clinical study involving 112 participants over 8 weeks demonstrated the effectiveness of JPL934®. The results showed that those who took JPL934® experienced significant relief from abdominal pain, discomfort, and bloating compared to the placebo group (p < 0.05). The study also found a notable increase in the levels of beneficial bacteria, such as Lactobacillus johnsonii and Bifidobacterium lactis, in the gut after supplementation.


  • Probiotic Strain Composition:

    • JPL934® contains a blend of three highly researched strains:

      • Lactobacillus johnsonii IDCC 9203

      • Lactobacillus plantarum IDCC 3501

      • Bifidobacterium lactis IDCC 4301


  • Clinical Efficacy:

    • A clinical study was conducted on 112 participants over 8 weeks.

    • Results showed significant symptom relief in those taking JPL934® compared to the placebo group:

      • Abdominal pain: Reduced by -1.83 points compared to -1.06 points in the placebo group (p < 0.05).

      • Bloating: Reduced by -2.03 points versus -0.84 points in the placebo group (p < 0.05).

      • General discomfort: Improvement trends were also observed, showing JPL934® was effective in improving multiple symptoms.


  • Microbiome Impact:

    • The levels of Lactobacillus johnsonii and Bifidobacterium lactis in the gut were significantly increased after JPL934® supplementation, confirming that these beneficial strains proliferated effectively in the gut (p < 0.05).


  • Reduction of Inflammatory Markers:

    • The probiotic also contributed to a significant reduction in serum IL-6 levels, a marker associated with inflammation, which decreased by p < 0.001 in the JPL934® group.


Advanced Probiotic Technology: Q-shield® Coating

What sets JPL934® apart from other probiotics on the market is ILDONG Bioscience’s proprietary Q-shield® technology. This four-layer coating system ensures that the probiotics remain viable as they pass through the digestive tract, protecting them from stomach acid and bile. Without this advanced coating, many probiotics may not survive the journey to the intestines, where they are needed most.

The Q-shield® coating significantly enhances the probiotics’ ability to adhere to the gut lining and effectively inhibit harmful bacteria. This ensures that JPL934® delivers superior results compared to non-coated probiotics, offering longer-lasting benefits for gut health.


Why Choose JPL934® for Gut Health

With the global probiotics market on the rise, JPL934® from ILDONG Bioscience stands out as a trusted and effective solution for those looking to improve their digestive health. Whether you're dealing with occasional bloating and discomfort or looking for a proactive way to maintain a healthy gut, JPL934® offers proven results backed by clinical data. The combination of its potent probiotic strains and the cutting-edge Q-shield® technology makes it an excellent choice for anyone seeking better gut health.


As gut health continues to gain importance in the wellness landscape, JPL934® is poised to help individuals worldwide achieve optimal digestive balance. ILDONG Bioscience’s commitment to innovation and quality ensures that JPL934® is more than just a supplement—it’s a trusted partner in your journey toward better health.

ILDONG Bioscience Co., Ltd.

17, Poseunggongdan-ro, Poseung-eup, Pyeongtaek-si, Gyeonggi-do, Republic of Korea

Tel: +822-6956-3113
E-mail: bioexport@ildong.com

ILDONG Bioscience Co., Ltd. |Copyright © 2016-2024

  • LinkedIn
  • YouTube
bottom of page